ASCENT procurement announcement: Requests for quotation

The ASCENT project has two requests for quotation (RFQ’s): 1. For printing of cardstock medication sleeves. 2. To facilitate incoming and outgoing interactions with adherence platform.

Submitted questions and answers about these RFQ’s can be found here.

KNCV Tuberculosis Foundation

KNCV Tuberculosis Foundation (KNCV) is an international non-profit organization dedicated to the fight against tuberculosis (TB), still the second most deadly infectious disease in the world. KNCV is an international center of expertise for TB control that promotes effective, efficient, innovative and sustainable TB control strategies in a national and international context. We are an organization of passionate TB professionals, including doctors, researchers, training experts, nurses and epidemiologists. We aim to stop the spread of the worldwide epidemic of TB and to prevent the further spread of drug-resistant TB.

The ASCENT project

ASCENT (Adherence Support Coalition to End TB) is a Unitaid funded project to help patients successfully complete their course of treatment through the use of digital adherence technologies and data-driven support interventions, utilizing tools such as smart pill boxes and other innovations. The project will be implemented from July 2019 until December 2022 and aims to reach nearly 70.000 patients in Ukraine, Ethiopia, Tanzania, South Africa and the Philippines. These digital adherence technologies empower patients to take their daily medication at a time and place that suits them best. Additionally they provide real-time information to the TB doctor or nurse, helping to determine the most appropriate treatment approach for each individual patient and by enabling focused efforts on those patients that require extra support.

To facilitate these data driven support interventions, patients log their dose on a daily basis so that their medication intake behavior is displayed in real-time (Android app and web dashboard) and health care providers can provide individual targeted care. In addition, outgoing communication (motivational / educational messages) can be triggered by the adherence platform as well.

Objective of RFQ 1

To print cardstock medication sleeves used for repacking of existing Fixed-Dose Combination (FDC) antibiotic medication blister packs for Tuberculosis (TB) in multiple or selected countries that implement the ASCENT project. Download the full procurement announcement here.

Objective of RFQ 2

To implement and maintain the technical communication infrastructure to facilitate incoming and outgoing interactions with an adherence platform in multiple or selected countries that implement the ASCENT project. Download the full procurement announcement here.


First contractual period will be from 1st of March 2020 – 1st of March 2021  with the possibility to extent. The candidate should be capable to start activities within 1 month after contract signing.


This RFQ is published from 13th of January to 31st of January 2020 on the ASCENT and KNCV Tuberculosis Foundation website. Review and selection will take place from 1st of February –  14th of February 2020.


Proposals should be submitted via and must be received by 11:59 CET on 31st of January 2020. Proposals received after this date and time shall be invalid and will be blocked from review. Proposals should be submitted in English and each interested party shall submit only one quotation. The quotation needs to include the following documents:

  1. Completed Requirements document
  2. Completed Budget


Selection of the candidate(s) will be based upon independent assessment of the proposals by a review committee consisting of in-country and external specialists. KNCV will evaluate all quotations based on the following criteria:

  1. Overall suitability: proposed solutions must meet the scope and be presented in a clear and organized manner.
  2. Organizational experience: Organizations will be evaluated on their experience related to the scope of this RFQ.
  3. Value and cost: Organizations will be evaluated on the cost of their solution(s) based on the work to be performed in accordance with the scope of this project.

Questions and contact

KNCV reserves the right to request further information during the RFQ process. Questions regarding requirements described in this RFQ must be directed in writing via email to before the 24th of January 2020. Responses to questions and / or clarifications can be found here.

Read more about the ASCENT project.


KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us


De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.